澳大利亚政党One Nation对政府补贴处方药流入黑市表示担忧[1]。虽然已知某些药物存在被滥用情况，但目前难以精确判断问题的实际规模、增长趋势及对纳税人的成本影响[1]。根据数据，黑市上处方药价格范围为1至30澳元每片[1]，而2022-23年澳大利亚14岁及以上人口中约1/20在过去12个月内报告使用过非医疗用途的药物[1]。
近年来政府补贴药物欺诈案件时有发生。2025年澳大利亚联邦警察从新南威尔士州一药剂师手中没收超2000万澳元资产，涉及超1000万澳元的药物福利计划（PBS）欺诈指控[1]。此前，维州一药剂师2023年2月因提交76份虚假PBS申请被判2年监禁，涉及金额超11万澳元[1]；布里斯班一药剂师2022年因PBS欺诈近200万澳元被法院下令赔偿190万澳元[1]。2023年联邦政府委托报告估计医疗保险欺诈和不合规价值约每年15至30亿澳元，但未单独列出PBS欺诈数字[1]。2024年审计长报告发现过时IT系统增加了PBS欺诈风险[1]。
Australian political party One Nation has expressed alarm about subsidized prescription medications from the Pharmaceutical Benefits Scheme (PBS) being diverted to the illegal market.[1] While certain PBS drugs are known to be subject to misuse, the precise scale of the problem, its growth trajectory, and the financial impact on taxpayers remain difficult to determine.[1]
The issue has drawn regulatory attention through several high-profile cases. In 2025, the Australian Federal Police seized over A$20 million in assets from a New South Wales pharmacist facing allegations involving more than A$10 million in PBS fraud.[1] A Victorian pharmacist was sentenced to two years imprisonment in February 2023 after submitting 76 fraudulent PBS claims worth over A$110,000.[1] A Brisbane pharmacist was ordered by the court to pay A$1.9 million in compensation for PBS fraud estimated at approximately A$1.8 million.[1] A 2024 audit report identified outdated IT systems as a contributing factor to PBS fraud risk.[1]
The extent of non-medical drug use remains substantial within the broader Australian population. In 2022–23, approximately one in twenty Australians aged 14 and over reported using drugs for non-medical purposes in the past 12 months.[1] On the black market, prescription drugs range in price from A$1 to A$30 per tablet according to the StreetRx database.[1] A 2023 federal government commissioned report estimated healthcare fraud and non-compliance costs at approximately A$1.5 to A$3 billion annually, though PBS fraud figures were not itemized separately.[1]
